Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study on the Application of Hyperspectral Imaging Technique in CTX Treatment of IMN

NCT05850845 is registered in ClinicalTrials.gov with Qianfoshan Hospital as lead sponsor.

NCT NCT05850845
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05850845 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study on the Application of Hyperspectral Imaging Technique in CTX Treatment of IMN
Lead sponsor
Qianfoshan Hospital
Phase
Observational
Overall status
Unknown status
Start date
June 25, 2023
Completion date
December 30, 2023
Enrollment
40 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cyclophosphamide, hyperspectral imaging, idiopathic membranous nephropathy